ORALE CANNABINOID-REZEPTORMODULATORFORMULIERUNGEN

Patent europeic · EP3735239 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3735239
Numer da la dumonda
EP19705249
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-01-2019
Publitgà
11-11-2020
Concedì
06-05-2026
La protecziun finescha il pli tard
06-01-2039
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 31/4525 (2006.01)
A61K 9/20 (2006.01)
A61P 25/30 (2006.01)
A61P 25/02 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201815862721 05.01.2018
Dumonda PCT
PCT/US2019/012459 07.01.2019
Publicaziun PCT
WO2019/136331 11.07.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 06-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.05.2026

Partidas

Inventur

FOSS, Joseph

Cleveland, Ohio 44195, US

ATTALA, Mohamed Naguib

Cleveland, Ohio 44195, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.